Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 8,285 | 6,888 | 10,860 | 19,289 | 10,928 |
| Operating Income | -8,285 | -6,888 | -10,860 | -19,289 | -10,928 |
| Other Income | -4,913 | -114 | 63 | -229 | 35 |
| Pre-tax Income | -13,198 | -7,002 | -10,796 | -19,517 | -10,893 |
| Income Tax | N/A | N/A | N/A | -94 | N/A |
| Net Income Continuous | -13,198 | -7,002 | -10,796 | -19,423 | -10,893 |
| Net Income Discontinuous | N/A | 1,879 | -1,935 | N/A | N/A |
| Net Income | $-13,198 | $-5,123 | $-12,731 | $-19,423 | $-10,893 |
| EPS Basic Total Ops | -2.72 | -3.60 | -12.71 | -26.00 | -21.75 |
| EPS Basic Continuous Ops | -2.72 | -4.91 | -10.78 | -26.12 | -21.85 |
| EPS Basic Discontinuous Ops | N/A | -1.32 | -1.93 | N/A | N/A |
| EPS Diluted Total Ops | -2.72 | -3.60 | -12.71 | -26.00 | -21.75 |
| EPS Diluted Continuous Ops | -2.72 | -4.91 | -10.78 | -26.12 | -21.85 |
| EPS Diluted Discontinuous Ops | N/A | -1.32 | -1.93 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.80 | -4.91 | -12.75 | -26.00 | -21.75 |
| EBITDA(a) | $-8,284 | $-6,887 | $-10,859 | $-19,234 | $-10,927 |